Results of a phase Ⅱ study of concurrent 5-fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus
CHEN Yun1, AI Tashan1, XIA Yi2, LIU Qi1, ZHANG Junhua1, ZHAO Kuaile1
1. Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; 2. Department of Radiation Oncology, Shanghai Minhang District Cancer Hospital, Shanghai 200240, China
CHEN Yun, AI Tashan, XIA Yi, et al. Results of a phase Ⅱ study of concurrent 5-fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus[J]. China Oncology, 2016, 26(11): 926-931.